BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7725670)

  • 1. K12 is located on the Kell blood group protein in proximity to K/k and Jsa/Jsb.
    Reid ME; Oyen R; Redman CM; Gillespie G; Jones J; Eckrich R
    Vox Sang; 1995; 68(1):40-5. PubMed ID: 7725670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens.
    Jones J; Reid ME; Oyen R; Harris T; Moscarelli S; Co S; Leger R; Beal C; Cardillo K
    Vox Sang; 1995; 69(1):53-60. PubMed ID: 7483493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the MAIEA assay to the Kell blood group system.
    Petty AC; Daniels GL; Tippett P
    Vox Sang; 1994; 66(3):216-24. PubMed ID: 7518625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system.
    Daniels GL; Petty AC; Reid M; Moulds M; Devenish A; Halil O
    Transfusion; 1994 Sep; 34(9):818-20. PubMed ID: 8091473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).
    Jongerius JM; Daniels GL; Overbeeke MA; Petty AC; Reid M; Oyen R; Rijksen H; van Leeuwen EF
    Vox Sang; 1996; 71(1):43-7. PubMed ID: 8837356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody-specific immobilisation of erythrocyte antigens (MAIEA). A new technique to selectively determine antigenic sites on red cell membranes.
    Petty AC
    J Immunol Methods; 1993 May; 161(1):91-5. PubMed ID: 8486932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine monoclonal antibody against Kx protein which reacts also with beta-spectrin.
    Carbonnet F; Blanchard D; Hattab C; Cochet S; Petit-Leroux Y; Loirat MJ; Cartron JP; Bertrand O
    Transfus Med; 2000 Jun; 10(2):145-54. PubMed ID: 10849386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells.
    Branch DR; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1985 Mar; 59(3):505-12. PubMed ID: 2578808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Kell blood group phenotypes.
    Lee S
    Vox Sang; 1997; 73(1):1-11. PubMed ID: 9269063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity.
    Branch DR; Muensch HA; Sy Siok Hian AL; Petz LD
    Br J Haematol; 1983 Aug; 54(4):573-8. PubMed ID: 6871108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired loss of red cell Kell antigens.
    Vengelen-Tyler V; Gonzalez B; Garratty G; Kruppe C; Johnson CL; Mueller KA; Marsh WL
    Br J Haematol; 1987 Feb; 65(2):231-4. PubMed ID: 3828231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to high-incidence Kell epitopes: characterization and application in automated screening of donor samples.
    Inglis G; Fraser RH; McTaggart S; Sheridan R; Forrest AH; Mitchell R
    Transfus Med; 1994 Sep; 4(3):209-12. PubMed ID: 7820228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed hemolytic transfusion reaction caused by the second example of anti-K19.
    Marsh WL; DiNapoli J; Oyen R; Greenspan R; Hu A; Rincon F
    Transfusion; 1979; 19(5):604-8. PubMed ID: 505537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of anti-kell monoclonal antibodies using transfected cells as the immunogen.
    Chu TH; Yazdanbakhsh K; Oyen R; Smart E; Reid ME
    Br J Haematol; 1999 Sep; 106(3):817-23. PubMed ID: 10468879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Ko phenotype and fetal-maternal allo-immunization].
    Fourmaintraux A; Vitrac D; Mariette JB; Brunel F
    Arch Fr Pediatr; 1993 Nov; 50(9):779-81. PubMed ID: 8060208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K22, a 'new' para-Kell antigen of high frequency.
    Bar Shany S; Ben Porath D; Levene C; Sela R; Daniels GL
    Vox Sang; 1982 Feb; 42(2):87-90. PubMed ID: 7064432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human and chimpanzee Kell blood group systems.
    Redman CM; Lee S; ten Huinink D; Rabin BI; Johnson CL; Oyen R; Marsh WL
    Transfusion; 1989; 29(6):486-90. PubMed ID: 2749871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual suppression of Kell system antigens in a healthy blood donor.
    Norman PC; Daniels GL
    Transfusion; 1988; 28(5):460-2. PubMed ID: 3420674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system.
    Lee S; Wu X; Reid M; Redman C
    Transfusion; 1995 Oct; 35(10):822-5. PubMed ID: 7570911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.